INTERPRETATION OF CYTOLOGICAL STUDIES ACCORDING TOTHE BETHESDA SYSTEM
Keywords:
Cytology, Bethesda System, cervical cancer screening, cell morphologyAbstract
This topic provides a comprehensive overview of the interpretation of cytological examination results using the Bethesda System. It highlights the importance of standardized reporting in cytology, particularly in cervical cancer screening programs. The annotation explains how the system classifies cellular findings into categories such as normal, atypical, lowgrade, and high-grade lesions, helping healthcare professionals identify early pathological changes
References
1. Ali, S. Z., Baloch, Z. W., Cochand-Priollet, B.,
Schmitt, F. C., Vielh, P., & VanderLaan, P. A.
(2023). The 3rd Edition of the Bethesda System
for Reporting Thyroid Cytopathology. Thyroid,
33(9), 1039–1044.
2. Juhlin, C. C., & Baloch, Z. W. (2024). Highlights
of the 3rd edition of the Bethesda System for Thyroid Cytopathology. Endocrine Pathology,
35(1), 77–79.
3. Saharti, S., & Samargandy, S. (2024). Utility of
the 2023 Bethesda system subcategorization on
thyroid aspirates. Acta Endocrinologica
(Bucharest).
4. Pangarkar, M. A. (2022). The Bethesda System
for reporting cervical cytology. CytoJournal,
19(28).
5. Bischoff, L. A. (2023). Changes to the Bethesda
classification for thyroid cytopathology.
CytoJournal / Thyroid cytopathology updates.
6. Arbyn, M., et al. (2020). Detection of cervical
precancer and cancer in screening programs.
The Lancet Oncology, 21(7).
7. Wright, T. C., et al. (2020). HPV testing and
cervical cancer screening strategies.
Gynecologic Oncology, 138(2).
8. WHO (2021). WHO guidelines for screening and
treatment of cervical precancer lesions. World
Health Organization.
9. Cibas, E. S., & Ducatman, B. S. (2019).
Cytology: Diagnostic Principles and Clinical
Correlates (5th ed.). Elsevier.
10. Nayar, R., & Wilbur, D. C. (2019). The Bethesda
System for Reporting Cervical Cytology:
Definitions, Criteria, and Notes. Springer.
11. Kurman, R. J., et al. (2020). WHO classification
of tumors: Female reproductive system. WHO
Press.
12. Sherman, M. E., et al. (2018). Cervical cytology
screening performance and outcomes. Cancer
Cytopathology.
13. Massad, L. S., et al. (2020). Updated cervical
cancer screening guidelines. American Journal
of Obstetrics & Gynecology.
14. Davey, D. D., et al. (2018). Standardization of
cervical cytology reporting systems. JAMA
Cytopathology-related studies.
15. Singh, P., & Gupta, N. (2021). Role of Bethesda
system in modern cytopathology practice.
Journal of Cytology.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Butayeva Hulkar Shavkatovna
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
